These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The influence of physical properties and morphology of crystallised lactose on delivery of salbutamol sulphate from dry powder inhalers. Kaialy W, Martin GP, Larhrib H, Ticehurst MD, Kolosionek E, Nokhodchi A. Colloids Surf B Biointerfaces; 2012 Jan 01; 89():29-39. PubMed ID: 21962946 [Abstract] [Full Text] [Related]
4. Engineered mannitol as an alternative carrier to enhance deep lung penetration of salbutamol sulphate from dry powder inhaler. Kaialy W, Momin MN, Ticehurst MD, Murphy J, Nokhodchi A. Colloids Surf B Biointerfaces; 2010 Sep 01; 79(2):345-56. PubMed ID: 20537870 [Abstract] [Full Text] [Related]
18. Antisolvent crystallisation is a potential technique to prepare engineered lactose with promising aerosolisation properties: effect of saturation degree. Kaialy W, Nokhodchi A. Int J Pharm; 2012 Nov 01; 437(1-2):57-69. PubMed ID: 22884837 [Abstract] [Full Text] [Related]
19. The influence of carrier morphology on drug delivery by dry powder inhalers. Zeng XM, Martin GP, Marriott C, Pritchard J. Int J Pharm; 2000 Apr 25; 200(1):93-106. PubMed ID: 10845690 [Abstract] [Full Text] [Related]
20. Comparison of spray congealing and melt emulsification methods for the incorporation of the water-soluble salbutamol sulphate in lipid microparticles. Scalia S, Traini D, Young PM, Di Sabatino M, Passerini N, Albertini B. Pharm Dev Technol; 2013 Feb 25; 18(1):266-73. PubMed ID: 22998063 [Abstract] [Full Text] [Related] Page: [Next] [New Search]